Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP

Clinical trial NCT00144534 · COMPLETED

Trial details

NCT number: NCT00144534
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2004-06-01
Primary completion: 2005-08-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.